Paying users zone. Data is covered by .
Get to Eli Lilly & Co. for $19.99, or
get to entire website for at least 3 months from $49.99.







Current Ratio
since 2005
Difficulty: Beginner
Calculation
Eli Lilly & Co., current ratio, long-term trends, calculation
Current Ratio | = | Current assets1 | ÷ | Current liabilities1 | |
---|---|---|---|---|---|
Dec 31, 2005 | ![]() |
= | ![]() |
÷ | ![]() |
Dec 31, 2006 | ![]() |
= | ![]() |
÷ | ![]() |
Dec 31, 2007 | ![]() |
= | ![]() |
÷ | ![]() |
Dec 31, 2008 | ![]() |
= | ![]() |
÷ | ![]() |
Dec 31, 2009 | ![]() |
= | ![]() |
÷ | ![]() |
Dec 31, 2010 | ![]() |
= | ![]() |
÷ | ![]() |
Dec 31, 2011 | ![]() |
= | ![]() |
÷ | ![]() |
Dec 31, 2012 | ![]() |
= | ![]() |
÷ | ![]() |
Dec 31, 2013 | ![]() |
= | ![]() |
÷ | ![]() |
Dec 31, 2014 | ![]() |
= | ![]() |
÷ | ![]() |
Dec 31, 2015 | ![]() |
= | ![]() |
÷ | ![]() |
Dec 31, 2016 | ![]() |
= | ![]() |
÷ | ![]() |
Dec 31, 2017 | ![]() |
= | ![]() |
÷ | ![]() |
Dec 31, 2018 | ![]() |
= | ![]() |
÷ | ![]() |
Based on: 10-K (filing date: 2006-03-01), 10-K (filing date: 2007-02-28), 10-K (filing date: 2008-02-29), 10-K (filing date: 2009-02-27), 10-K (filing date: 2010-02-22), 10-K (filing date: 2011-02-22), 10-K (filing date: 2012-02-24), 10-K (filing date: 2013-02-21), 10-K (filing date: 2014-02-19), 10-K (filing date: 2015-02-19), 10-K (filing date: 2016-02-19), 10-K (filing date: 2017-02-21), 10-K (filing date: 2018-02-20), 10-K (filing date: 2019-02-19).
1 USD $ in thousands
Comparison to Competitors
Eli Lilly & Co., current ratio, long-term trends, comparison to competitors
Eli Lilly & Co. | Abbott Laboratories | AbbVie Inc. | Allergan PLC | Amgen Inc. | Biogen Inc. | Bristol-Myers Squibb Co. | Celgene Corp. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2005 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Dec 31, 2006 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Dec 31, 2007 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Dec 31, 2008 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Dec 31, 2009 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Dec 31, 2010 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Dec 31, 2011 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Dec 31, 2012 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Dec 31, 2013 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Dec 31, 2014 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Dec 31, 2015 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Dec 31, 2016 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Dec 31, 2017 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Dec 31, 2018 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Based on: 10-K (filing date: 2006-03-01), 10-K (filing date: 2007-02-28), 10-K (filing date: 2008-02-29), 10-K (filing date: 2009-02-27), 10-K (filing date: 2010-02-22), 10-K (filing date: 2011-02-22), 10-K (filing date: 2012-02-24), 10-K (filing date: 2013-02-21), 10-K (filing date: 2014-02-19), 10-K (filing date: 2015-02-19), 10-K (filing date: 2016-02-19), 10-K (filing date: 2017-02-21), 10-K (filing date: 2018-02-20), 10-K (filing date: 2019-02-19).
Comparison to Pharmaceuticals & Biotechnology Sector
Eli Lilly & Co., current ratio, long-term trends, comparison to Pharmaceuticals & Biotechnology sector
Eli Lilly & Co. | Pharmaceuticals & Biotechnology | |
---|---|---|
Dec 31, 2005 | ![]() |
![]() |
Dec 31, 2006 | ![]() |
![]() |
Dec 31, 2007 | ![]() |
![]() |
Dec 31, 2008 | ![]() |
![]() |
Dec 31, 2009 | ![]() |
![]() |
Dec 31, 2010 | ![]() |
![]() |
Dec 31, 2011 | ![]() |
![]() |
Dec 31, 2012 | ![]() |
![]() |
Dec 31, 2013 | ![]() |
![]() |
Dec 31, 2014 | ![]() |
![]() |
Dec 31, 2015 | ![]() |
![]() |
Dec 31, 2016 | ![]() |
![]() |
Dec 31, 2017 | ![]() |
![]() |
Dec 31, 2018 | ![]() |
![]() |
Based on: 10-K (filing date: 2006-03-01), 10-K (filing date: 2007-02-28), 10-K (filing date: 2008-02-29), 10-K (filing date: 2009-02-27), 10-K (filing date: 2010-02-22), 10-K (filing date: 2011-02-22), 10-K (filing date: 2012-02-24), 10-K (filing date: 2013-02-21), 10-K (filing date: 2014-02-19), 10-K (filing date: 2015-02-19), 10-K (filing date: 2016-02-19), 10-K (filing date: 2017-02-21), 10-K (filing date: 2018-02-20), 10-K (filing date: 2019-02-19).
Comparison to Health Care Industry
Eli Lilly & Co., current ratio, long-term trends, comparison to Health Care industry
Eli Lilly & Co. | Health Care | |
---|---|---|
Dec 31, 2005 | ![]() |
![]() |
Dec 31, 2006 | ![]() |
![]() |
Dec 31, 2007 | ![]() |
![]() |
Dec 31, 2008 | ![]() |
![]() |
Dec 31, 2009 | ![]() |
![]() |
Dec 31, 2010 | ![]() |
![]() |
Dec 31, 2011 | ![]() |
![]() |
Dec 31, 2012 | ![]() |
![]() |
Dec 31, 2013 | ![]() |
![]() |
Dec 31, 2014 | ![]() |
![]() |
Dec 31, 2015 | ![]() |
![]() |
Dec 31, 2016 | ![]() |
![]() |
Dec 31, 2017 | ![]() |
![]() |
Dec 31, 2018 | ![]() |
![]() |
Based on: 10-K (filing date: 2006-03-01), 10-K (filing date: 2007-02-28), 10-K (filing date: 2008-02-29), 10-K (filing date: 2009-02-27), 10-K (filing date: 2010-02-22), 10-K (filing date: 2011-02-22), 10-K (filing date: 2012-02-24), 10-K (filing date: 2013-02-21), 10-K (filing date: 2014-02-19), 10-K (filing date: 2015-02-19), 10-K (filing date: 2016-02-19), 10-K (filing date: 2017-02-21), 10-K (filing date: 2018-02-20), 10-K (filing date: 2019-02-19).